Fexofenadine + Pseudoephedrine Suppliers & Bulk Manufacturers

Available Forms: ER Tablet

Available Strengths: 12 Hr(Fexofenadine 60 mg + Pseudoephedrine 120 mg); 24 Hr(Fexofenadine 180 mg + Pseudoephedrine 240 mg)

Reference Brands: Allegra-D(US); Telfast-D(EU)

Category: Allergy Medication

Allegra-D / Telfast-D tablets combine Fexofenadine (60 mg/180 mg) with Pseudoephedrine (120 mg) for fast, non-drowsy allergy and congestion relief. Ideal for seasonal allergic rhinitis, approved for US and EU markets. Available for bulk supply, private labeling, and B2B distribution with full documentation. Fexofenadine + Pseudoephedrine is available in ER Tablet and strengths such as 12 Hr(Fexofenadine 60 mg + Pseudoephedrine 120 mg); 24 Hr(Fexofenadine 180 mg + Pseudoephedrine 240 mg). Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Fexofenadine + Pseudoephedrine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Fexofenadine + Pseudoephedrine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Allegra-D / Telfast-D – Fexofenadine + Pseudoephedrine Tablets | Pharma B2B EU & US Allegra-D / Telfast-D combines Fexofenadine HCl (60 mg or 180 mg) with Pseudoephedrine (120 mg) to offer powerful allergy and nasal decongestion relief. Widely used for seasonal allergic rhinitis, it delivers 24-hour, non-drowsy symptom control. Available in extended-release tablets, approved by US FDA and compliant with EU GMP standards. Ideal for B2B pharma distribution, bulk export, and private labeling. Includes full documentation: COA, MSDS, and stability data.